Sleep disorder and Progressive multifocal leukoencephalopathy

Summary:

Progressive multifocal leukoencephalopathy is found among people with Sleep disorder, especially for people who are female, 40-49 old.

The study analyzes which people have Progressive multifocal leukoencephalopathy with Sleep disorder. It is created by eHealthMe based on reports of 80 people who have Sleep disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Sleep disorder?

Sleep disorder is found to be associated with 2,103 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Sleep disorder.

What is Progressive multifocal leukoencephalopathy?

Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) is found to be associated with 593 drugs and 921 conditions by eHealthMe. Check the latest studies of Progressive multifocal leukoencephalopathy.



On Jul, 16, 2026

80 people who have Sleep Disorder and Progressive Multifocal Leukoencephalopathy are studied.

Would you have Progressive multifocal leukoencephalopathy when you have Sleep disorder?

Gender of people who have Sleep Disorder and experienced Progressive Multifocal Leukoencephalopathy *:

  • female: 73.97 %
  • male: 26.03 %

Age of people who have Sleep Disorder and experienced Progressive Multifocal Leukoencephalopathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.49 %
  • 30-39: 20.9 %
  • 40-49: 34.33 %
  • 50-59: 20.9 %
  • 60+: 22.39 %

Common co-existing conditions for these people *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 47 people, 58.75%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 23 people, 28.75%
  3. Pain: 21 people, 26.25%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 15 people, 18.75%
  5. Depression: 14 people, 17.50%
  6. Vasculitis (inflammation of a blood vessel or blood vessels): 12 people, 15.00%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 15.00%
  8. Stress And Anxiety: 11 people, 13.75%
  9. Hypersensitivity: 9 people, 11.25%
  10. Migraine (headache): 9 people, 11.25%

Common drugs taken by these people *:

  1. Tysabri: 50 people, 62.50%
  2. Prednisone: 24 people, 30.00%
  3. Atenolol: 24 people, 30.00%
  4. Cymbalta: 22 people, 27.50%
  5. Aspirin: 21 people, 26.25%
  6. Prevacid: 20 people, 25.00%
  7. Benadryl: 20 people, 25.00%
  8. Klonopin: 17 people, 21.25%
  9. Restoril: 15 people, 18.75%
  10. Methylprednisolone: 14 people, 17.50%

Common symptoms for these people *:

  1. Weakness: 22 people, 27.50%
  2. Fall: 22 people, 27.50%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 21 people, 26.25%
  4. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 20 people, 25.00%
  5. Depression: 19 people, 23.75%
  6. Dyspnea (difficult or laboured breathing): 17 people, 21.25%
  7. Coordination Abnormal (abnormal movement): 17 people, 21.25%
  8. Fatigue (feeling of tiredness): 15 people, 18.75%
  9. Dizziness: 15 people, 18.75%
  10. Cough: 14 people, 17.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Progressive multifocal leukoencephalopathy?

- Check whether Progressive multifocal leukoencephalopathy is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Progressive multifocal leukoencephalopathy:

All the conditions that are associated with Progressive multifocal leukoencephalopathy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Progressive multifocal leukoencephalopathy and Sleep disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: